These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8186662)

  • 21. [Intracavernous injection of prostaglandin E1 as a diagnostic test in erectile dysfunction].
    Marín Lafuente JC; Sańchez Moreno Horencia M; Puy Figuero Echeverría M; Llarena Ibarguren R; Pertusa Peña C
    Arch Esp Urol; 1990; 43(6):661-3. PubMed ID: 2092621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracavernous self-injection therapy for the treatment of erectile dysfunction.
    Chiang HS; Wen TC; Wu CC; Chiang WH
    J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF; Chu NK; Wong MK
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction.
    Schramek P; Waldhauser M
    Br J Clin Pharmacol; 1989 Nov; 28(5):567-71. PubMed ID: 2686740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Test with intracavernous injection of PGE1 in erectile dysfunction: our experience].
    Domínguez Domínguez M; Amaya Gutiérrez J; Blasco Hernández P; Vega Toro P; Alonso Flores J; García Pérez M
    Actas Urol Esp; 2000; 24(10):796-800. PubMed ID: 11199295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cavernous auto-injection therapy with prostaglandin E1.
    Nisén H
    Ann Chir Gynaecol Suppl; 1993; 206():69-73. PubMed ID: 8291874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
    Beretta G; Zanollo A; Portalupi W
    Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):481-5. PubMed ID: 1838836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E1 long-term self-injection programme for treatment of erectile dysfunction--a follow-up of at least 5 years.
    Hauck EW; Altinkilic BM; Schroeder-Printzen I; Rudnick J; Weidner W
    Andrologia; 1999; 31 Suppl 1():99-103. PubMed ID: 10643527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracavernous injection of prostaglandin E1: the application to cavernosography and penile blood flow measurement for the diagnosis of venogenic impotence.
    Ishigooka M; Irisawa C; Watanabe H; Adachi M; Ishii N; Nakada T
    Urol Int; 1991; 46(2):193-6. PubMed ID: 2053230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction.
    Schramek P; Plas EG; Hübner WA; Pflüger H
    J Urol; 1994 Oct; 152(4):1108-10. PubMed ID: 8072075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary results of a comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
    Martinez-Piñeiro L; Lopez-Tello J; Alonso Dorrego JM; Cisneros J; Cuervo E; Martinez-Piñeiro JA
    J Urol; 1995 May; 153(5):1487-90. PubMed ID: 7714974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic study on erection induced by intracavernous injection of prostaglandin E1].
    Watanabe H
    Nihon Hinyokika Gakkai Zasshi; 1990 May; 81(5):732-8. PubMed ID: 2376930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
    Floth A; Schramek P
    J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peyronie's-like plaque after penile injection of prostaglandin E1.
    Chen J; Godschalk M; Katz PG; Mulligan T
    J Urol; 1994 Sep; 152(3):961-2. PubMed ID: 8051767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
    Linet OI; Ogrinc FG
    N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
    Polito M; d'Anzeo G; Conti A; Muzzonigro G
    BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-administration in the pharmacological treatment of impotence.
    Bénard F; Lue TF
    Drugs; 1990 Mar; 39(3):394-8. PubMed ID: 2184008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracavernous injections of prostaglandin E1 for erectile dysfunction: patient satisfaction and quality of sex life on long-term treatment.
    Alexandre B; Lemaire A; Desvaux P; Amar E
    J Sex Med; 2007 Mar; 4(2):426-31. PubMed ID: 17367438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.